No Detail Found!

Dexketoprofen versus Tenoxicam in Acute Severe Pain Due to Primary Dysmenorrhea

Author(s)
Deniz Aka Satar Health Sciences University, Adana City Training and Research Hospital, Adana,
Salim Satar Health Sciences University, Adana City Training and Research Hospital, Adana, Turkiye
Muge Gulen Health Sciences University, Adana City Training and Research Hospital, Adana, Turkiye
Selen Acehan Health Sciences University, Adana City Training and Research Hospital, Adana, Turkiye
Nefise Tanridan Okcu Department of Obstetrics and Gynaecology, Health Sciences University, Adana City Training and Research Hospital, Adana, Turkiye
Gonca Koksaldi Sahin Health Sciences University, Adana City Training and Research Hospital, Adana, Turkiye
Abstract
Objective: To evaluate the analgaesic e cacy of tenoxicam and dexketoprofen in patients admitted to the Emergency Medicine (EM) Clinic with severe acute pain due to primary dysmenorrhea (PD). Study Design: Randomised-controlled trial. Place and Duration of the Study: Emergency Medicine Clinic, Health Sciences University, Adana City Training and Research Hospital, Adana, Turkiye, from January to December 2022. Methodology: Patients presenting with PD, were divided into two groups of 60 each, administered 50 mg dexketoprofen and 20 mg tenoxicam intravenously. Visual analogue scale (VAS) scores were recorded at the 15th, 30th, 60th, and 120th minutes. VAS scores and ?VAS scores were compared with the e ectiveness of drugs, the need for rescue drugs and its side-e ects. Results: Intravenous (IV) dexketoprofen was administered to 60 of the patients and IV tenoxicam was administered to another 60. At the time of admission, mean VAS scores of the patients were 8.8 ± 0.9 for the dexketoprofen group and 8.6 ± 0.8 for the tenoxicam group. The VAS scores of the dexketoprofen group were found to be statistically signi cantly lower after 30 minutes with lower need for rescue analgaesics. ?VAS scores of the dexketoprofen group were statistically signi cantly higher from the 30th minute. Conclusion: According to the VAS scoring, IV dexketoprofen was a more effective drug than IV tenoxicam in patients who were admitted to the EM clinic with severe pain due to PD.
Publication Details
Page(s) 160-165
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Primary dysmenorrhea, VAS score, Dexketoprofen
0

Citations

0

Downloads

124

Views